Volume dodolan perusahaan biontech.de (BNTX)
The investment potential of BioNTech SE (BNTX) is limited by fierce competition with capital-intensive oncology behemoths. The company's commercial revenue level clearly demonstrates this trend, where 2.80 serves as the final benchmark. Patents and regular vaccination payments provide stability, while future growth relies on the results of new clinical trials amid the saturation of legacy markets.
Rincian analitis perusahaan BioNTech SE
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Koefisien Total Utang marang Modal BioNTech SE|BNTX - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal BioNTech Inc.|BNTX - Utang perusahaan|Rasio utang marang nilai buku BioNTech SE|BNTX - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak BioNTech|Likuiditas darurat biontech.de
- data bathi bisnis lan rasio investasi:
BNTX - Bathi resik|Bathi mangsa ngarep BioNTech SE|BNTX - Pangali P/E|Pangali mangsa ngarep rega marang bathi biontech.de|BNTX - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan BioNTech SE|BNTX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan BioNTech|BNTX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan biontech.de|BNTX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioNTech SE
- statistik dodolan lan pendapatan perusahaan:
Analisis komprehensif perusahaan:BioNTech Pharma BNTX
Sales represent the aggregated cash flow from the realization of core products and services. The trend in the company's total sales reflects real-time operational efficiency. This metric allows for an assessment of market demand and the pace of intellectual property monetization. For BioNTech SE (BNTX), this flow is generated through the commercialization of mRNA technologies within global partnerships. Strategic alliances with pharma behemoths directly determine the scale of incoming revenue.
Perusahaan pesaing
Pendapatan lan volume dodolan argenx BVBA|Pendapatan perusahaan Abivax (ABVX)|admabiologics.com - Volume dodolan perusahaan|Pendapatan lan volume dodolan PTGX (Protagonist)|Immunovant Inc (IMVT) - Total pendapatan perusahaan|Kiniksa Pharmaceuticals Ltd - Pendapatan lan volume dodolan|GRFS: Pendapatan perusahaan|ADPT: Pendapatan lan volume dodolan|CLDX - Pendapatan reged perusahaan|Pendapatan perusahaan Aurinia Pharmaceuticals Inc.|Total pendapatan perusahaan BioCryst Pharmaceuticals, Inc. BCRX|Pendapatan perusahaan Vera Pharma (VERA)|Dianthus Corp - Volume dodolan perusahaan|Pharvaris N.V. - Dodolan perusahaan|Total dodolan perusahaan ABCL (abcellera.com)|Tourmaline Bio - Pendapatan lan volume dodolan|Total pendapatan perusahaan Precigen Inc|PHAR: Pendapatan lan volume dodolan|Dodolan perusahaan Nektar Corp|UPB (Upstream Bio Inc) - Pendapatan lan volume dodolan|ZBIO: Pendapatan dodolan perusahaan|Dodolan perusahaan IMNM (Immunome)|GOSS (Gossamer Bio Inc) - Pendapatan dodolan perusahaan|Pendapatan perusahaan KalVista Pharmaceuticals Inc KALV|Pendapatan reged perusahaan Septerna Pharma (SEPN)|Pieris Pharmaceuticals - Pendapatan lan volume dodolan|Total pendapatan perusahaan savarapharma.com|RIGL: Pendapatan lan volume dodolan|ANAB (AnaptysBio Inc) - Pendapatan perusahaan|Pendapatan perusahaan Astria Pharma|Volume dodolan perusahaan ENGN (enGene Corp)|Dodolan perusahaan RAPT (RAPT Therapeutics, Inc.)|Total dodolan perusahaan JBIO|Aclaris Therapeutics, Inc. - Dodolan perusahaan|KYTX: Volume dodolan perusahaan|TLSA - Pendapatan perusahaan|Pendapatan tahunan perusahaan CABA|VTYX: Pendapatan lan volume dodolan|theratech.com - Pendapatan dodolan perusahaan|AVTX (Avalo Therapeutics) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Eledon Pharmaceuticals Inc.|Pendapatan perusahaan Agenus Inc (AGEN)|CLYM (Climb Bio, Inc) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Zura Bio Limited ZURA|ATYR - Dodolan perusahaan|Adagene Corp - Pendapatan lan volume dodolan|IMA - Pendapatan lan volume dodolan|STTK (shattucklabs.com) - Dodolan perusahaan|Equillium - Pendapatan dodolan perusahaan|CNTB (Connect Biopharma Holdings) - Pendapatan lan volume dodolan|Immunic Inc (IMUX) - Pendapatan reged perusahaan|Pendapatan perusahaan Atara Biotherapeutics (ATRA)|Dodolan perusahaan inflarx.de IFRX|Pendapatan perusahaan X4 Pharma XFOR|ACET - Dodolan perusahaan|CELU: Dodolan perusahaan|INMB - Pendapatan lan volume dodolan|Barinthus Biotherapeutics plc (BRNS) - Pendapatan perusahaan|Volume dodolan perusahaan KZR|SABS (SAB Biotherapeutics, Inc) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Akari Therapeutics, Plc AKTX|Pendapatan lan volume dodolan ENLV|Pendapatan perusahaan QTTB (q32bio.com)|Pendapatan lan volume dodolan GOVX (GeoVax)|Pendapatan reged perusahaan Edesa Biotech Inc (EDSA)|IBIO - Pendapatan perusahaan|Total pendapatan perusahaan Carisma Therapeutics|XTL Biopharmaceuticals (XTLB) - Pendapatan perusahaan|Volume dodolan perusahaan BOLT|Dodolan perusahaan HCWB|APVO (Aptevo) - Total dodolan perusahaan|Pendapatan lan volume dodolan AIM|ADTX - Total pendapatan perusahaan|Pendapatan lan volume dodolan GRI (GRI Bio, Inc.)|XRTX - Dodolan perusahaan|Vyome Holdings - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan REVB (Revelation Biosciences Inc)|INDP (Indaptus) - Dodolan perusahaan|BiondVax Pharmaceuticals - Pendapatan dodolan perusahaan|Pendapatan perusahaan CalciMedica Inc|Affimed Therapeutics (AFMD) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan ALLK|HOOK - Total pendapatan perusahaan|Pendapatan lan volume dodolan IGMS (IGM Biosciences)|iTeos Pharma - Pendapatan perusahaan|OCEA - Pendapatan perusahaan|TCBP (tcbiopharm.com) - Volume dodolan perusahaan|THRD (Third Harmonic Bio, Inc.) - Dodolan perusahaan
